Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of pilocarpine mouthwash on symptoms and salivary flow rate
IRCT20200108046050N1Phase 3Completed
- Sponsor
- Tabriz University of Medical Sciences
- Start
- Nov 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of pilocarpine in xerostomia, sponsored by Tabriz University of Medical Sciences. Primary endpoints: Change in xerostomia symptoms and Change in salivary flow rate. Started Nov 2021; status: completed.
02
Drugs
pilocarpine
03
Conditions
xerostomia
Beyond the preview
Go deeper on IRCT20200108046050N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20200108046050N1.